Isomorphic Labs Targets $2B Round, Thrive Capital And Alphabet To Lead Investment - Alphabet (NASDAQ:GOOG
AI disclosure
Summary
Thrive Capital and Alphabet are leading new financing for Isomorphic Labs, the AI-powered drug discovery company.